Thoracic specimen registry for adults with chest conditions
Part of Cancer, Lungs & breathing clinical trials.
This study is a “specimen registry,” meaning it collects and stores samples from adults with chest (thoracic) diseases. It may help researchers better understand lung and chest conditions and improve future testing or treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- You must have, or be being checked for, a chest (thoracic) condition
- Your condition may be a chest mass or nodule (benign or cancer)
- Your condition may be lung or breathing disease like interstitial lung disease or COPD
- Your condition may be a chest infection or cancer that spread to the chest area
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical information from people with suspected or confirmed thoracic cancer. The goal is to learn more about these cancers and improve future care.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This study collects medical data and samples from people with newly diagnosed bronchial cancer to learn more about the disease. You may be able to join if you have not yet started treatment for this cancer.
This trial collects health information and samples (a “cancer repository”) to help researchers study cancer and cancer risk. You may be able to join if you’ve had cancer before or if you’re at higher risk or have concerning findings.
This study is a registry that collects information from people who have tumors in the chest. It may include people receiving active treatment or only comfort (palliative) care, helping researchers learn about these conditions.
This study collects tissue (and follows patients over time) to better understand the natural course of several types of chest cancers. It may help researchers learn which tests and treatments work best in different cancer types.
Hear when a new Thoracic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.